Cargando…

Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes

Diffuse large B-cell lymphoma (DLBCL) is well known for selectively involving certain extranodal locations such as the central nervous system (CNS), testes, and skin. DLBCL or high-grade B-cell lymphoma selectively involving the bone marrow is rare and has been sparsely reported in the medical liter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimbrough, ErinMarie O, Jiang, Liuyan, Parent, Ephraim E, Bourgeois, Kirk, Alhaj Moustafa, Muhamad, Tun, Han W, Iqbal, Madiha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673799/
https://www.ncbi.nlm.nih.gov/pubmed/36405430
http://dx.doi.org/10.2147/JBM.S384983
_version_ 1784833024631767040
author Kimbrough, ErinMarie O
Jiang, Liuyan
Parent, Ephraim E
Bourgeois, Kirk
Alhaj Moustafa, Muhamad
Tun, Han W
Iqbal, Madiha
author_facet Kimbrough, ErinMarie O
Jiang, Liuyan
Parent, Ephraim E
Bourgeois, Kirk
Alhaj Moustafa, Muhamad
Tun, Han W
Iqbal, Madiha
author_sort Kimbrough, ErinMarie O
collection PubMed
description Diffuse large B-cell lymphoma (DLBCL) is well known for selectively involving certain extranodal locations such as the central nervous system (CNS), testes, and skin. DLBCL or high-grade B-cell lymphoma selectively involving the bone marrow is rare and has been sparsely reported in the medical literature. We report two cases of lymphoma presenting with primary bone marrow involvement without evidence of involvement of any other sites. The first case represents de novo DLBCL. The patient achieved complete remission with initial treatment, had a bone marrow-only relapse three years later, and achieved a second complete remission following non-transplant salvage therapy. The second case had findings consistent with “double hit” Richter’s transformation of chronic lymphocytic leukemia with translocation of c-MYC and BCL-2. This patient had an aggressive clinical course characterized by rapid progression with CNS involvement within three months resulting in the demise of the patient. These two cases represent two distinct subtypes of primary bone marrow lymphoma: de novo and transformed. Further research is necessary to gain a better understanding of this rare lymphoma entity and develop novel therapies.
format Online
Article
Text
id pubmed-9673799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96737992022-11-19 Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes Kimbrough, ErinMarie O Jiang, Liuyan Parent, Ephraim E Bourgeois, Kirk Alhaj Moustafa, Muhamad Tun, Han W Iqbal, Madiha J Blood Med Case Series Diffuse large B-cell lymphoma (DLBCL) is well known for selectively involving certain extranodal locations such as the central nervous system (CNS), testes, and skin. DLBCL or high-grade B-cell lymphoma selectively involving the bone marrow is rare and has been sparsely reported in the medical literature. We report two cases of lymphoma presenting with primary bone marrow involvement without evidence of involvement of any other sites. The first case represents de novo DLBCL. The patient achieved complete remission with initial treatment, had a bone marrow-only relapse three years later, and achieved a second complete remission following non-transplant salvage therapy. The second case had findings consistent with “double hit” Richter’s transformation of chronic lymphocytic leukemia with translocation of c-MYC and BCL-2. This patient had an aggressive clinical course characterized by rapid progression with CNS involvement within three months resulting in the demise of the patient. These two cases represent two distinct subtypes of primary bone marrow lymphoma: de novo and transformed. Further research is necessary to gain a better understanding of this rare lymphoma entity and develop novel therapies. Dove 2022-11-14 /pmc/articles/PMC9673799/ /pubmed/36405430 http://dx.doi.org/10.2147/JBM.S384983 Text en © 2022 Kimbrough et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Series
Kimbrough, ErinMarie O
Jiang, Liuyan
Parent, Ephraim E
Bourgeois, Kirk
Alhaj Moustafa, Muhamad
Tun, Han W
Iqbal, Madiha
Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
title Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
title_full Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
title_fullStr Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
title_full_unstemmed Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
title_short Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
title_sort primary bone marrow lymphoma: de novo and transformed subtypes
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673799/
https://www.ncbi.nlm.nih.gov/pubmed/36405430
http://dx.doi.org/10.2147/JBM.S384983
work_keys_str_mv AT kimbrougherinmarieo primarybonemarrowlymphomadenovoandtransformedsubtypes
AT jiangliuyan primarybonemarrowlymphomadenovoandtransformedsubtypes
AT parentephraime primarybonemarrowlymphomadenovoandtransformedsubtypes
AT bourgeoiskirk primarybonemarrowlymphomadenovoandtransformedsubtypes
AT alhajmoustafamuhamad primarybonemarrowlymphomadenovoandtransformedsubtypes
AT tunhanw primarybonemarrowlymphomadenovoandtransformedsubtypes
AT iqbalmadiha primarybonemarrowlymphomadenovoandtransformedsubtypes